These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31249407)

  • 1. Best practices and benchmarks for intact protein analysis for top-down mass spectrometry.
    Donnelly DP; Rawlins CM; DeHart CJ; Fornelli L; Schachner LF; Lin Z; Lippens JL; Aluri KC; Sarin R; Chen B; Lantz C; Jung W; Johnson KR; Koller A; Wolff JJ; Campuzano IDG; Auclair JR; Ivanov AR; Whitelegge JP; Paša-Tolić L; Chamot-Rooke J; Danis PO; Smith LM; Tsybin YO; Loo JA; Ge Y; Kelleher NL; Agar JN
    Nat Methods; 2019 Jul; 16(7):587-594. PubMed ID: 31249407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard Proteoforms and Their Complexes for Native Mass Spectrometry.
    Schachner LF; Ives AN; McGee JP; Melani RD; Kafader JO; Compton PD; Patrie SM; Kelleher NL
    J Am Soc Mass Spectrom; 2019 Jul; 30(7):1190-1198. PubMed ID: 30963455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Strategies to Address the Challenges in Top-Down Proteomics.
    Melby JA; Roberts DS; Larson EJ; Brown KA; Bayne EF; Jin S; Ge Y
    J Am Soc Mass Spectrom; 2021 Jun; 32(6):1278-1294. PubMed ID: 33983025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms.
    Tucholski T; Ge Y
    Mass Spectrom Rev; 2022 Mar; 41(2):158-177. PubMed ID: 32894796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding Proteoform Identifications in Top-Down Proteomic Analyses by Constructing Proteoform Families.
    Schaffer LV; Shortreed MR; Cesnik AJ; Frey BL; Solntsev SK; Scalf M; Smith LM
    Anal Chem; 2018 Jan; 90(2):1325-1333. PubMed ID: 29227670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering combinatorial post-translational modifications by top-down mass spectrometry.
    Brodbelt JS
    Curr Opin Chem Biol; 2022 Oct; 70():102180. PubMed ID: 35779351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top or Middle? Up or Down? Toward a Standard Lexicon for Protein Top-Down and Allied Mass Spectrometry Approaches.
    Lermyte F; Tsybin YO; O'Connor PB; Loo JA
    J Am Soc Mass Spectrom; 2019 Jul; 30(7):1149-1157. PubMed ID: 31073892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry for proteomics.
    Han X; Aslanian A; Yates JR
    Curr Opin Chem Biol; 2008 Oct; 12(5):483-90. PubMed ID: 18718552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database.
    Dai Y; Buxton KE; Schaffer LV; Miller RM; Millikin RJ; Scalf M; Frey BL; Shortreed MR; Smith LM
    J Proteome Res; 2019 Oct; 18(10):3671-3680. PubMed ID: 31479276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
    Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
    J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Human Sperm Protamine Proteoforms through a Combination of Top-Down and Bottom-Up Mass Spectrometry Approaches.
    Soler-Ventura A; Gay M; Jodar M; Vilanova M; Castillo J; Arauz-Garofalo G; Villarreal L; Ballescà JL; Vilaseca M; Oliva R
    J Proteome Res; 2020 Jan; 19(1):221-237. PubMed ID: 31703166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Tucholski T; Knott SJ; Chen B; Pistono P; Lin Z; Ge Y
    Anal Chem; 2019 Mar; 91(6):3835-3844. PubMed ID: 30758949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a routine application of Top-Down approaches for label-free discovery workflows.
    Schmit PO; Vialaret J; Wessels HJCT; van Gool AJ; Lehmann S; Gabelle A; Wood J; Bern M; Paape R; Suckau D; Kruppa G; Hirtz C
    J Proteomics; 2018 Mar; 175():12-26. PubMed ID: 28855124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete posttranslational modification mapping of pathogenic Neisseria meningitidis pilins requires top-down mass spectrometry.
    Gault J; Malosse C; Machata S; Millien C; Podglajen I; Ploy MC; Costello CE; Duménil G; Chamot-Rooke J
    Proteomics; 2014 May; 14(10):1141-51. PubMed ID: 24459079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cardiac troponin proteoforms by top-down mass spectrometry.
    Tiambeng TN; Tucholski T; Wu Z; Zhu Y; Mitchell SD; Roberts DS; Jin Y; Ge Y
    Methods Enzymol; 2019; 626():347-374. PubMed ID: 31606082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis of Top-Down Mass Spectrometry Data with ProSight Lite.
    DeHart CJ; Fellers RT; Fornelli L; Kelleher NL; Thomas PM
    Methods Mol Biol; 2017; 1558():381-394. PubMed ID: 28150248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding protein modifications using top-down mass spectrometry.
    Siuti N; Kelleher NL
    Nat Methods; 2007 Oct; 4(10):817-21. PubMed ID: 17901871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can platelet proteomics best be used to interrogate disease?
    Zellner M
    Platelets; 2023 Dec; 34(1):2220046. PubMed ID: 37272536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-intensive top-down proteomics: an update on technology advancements and biomedical applications.
    Xu T; Wang Q; Wang Q; Sun L
    Anal Methods; 2024 Jul; 16(28):4664-4682. PubMed ID: 38973469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Top-Down Proteomics and the Analysis of Proteoforms.
    Toby TK; Fornelli L; Kelleher NL
    Annu Rev Anal Chem (Palo Alto Calif); 2016 Jun; 9(1):499-519. PubMed ID: 27306313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.